Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences's investors include National Science Foundation, NJEDA, Hatch Biofund Management.
Optimeos Life Sciences is headquartered in Princeton, United States.
Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optimeos Life Sciences — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/optimeos-life-sciences. Accessed September 29, 2026.
VCBacked. (2026). Optimeos Life Sciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/optimeos-life-sciences
{{cite web |title=Optimeos Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/optimeos-life-sciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated